Publications by authors named "Manjari Lal"

Claim this Profile
D
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant.
Marcus Estrada, Changcheng Zhu, Anan Bzami, Jessica A White, Manjari Lal

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of multidose thermotolerant formulations of a vector-based Covid-19 vaccine candidate, NDV-HXP-S in different product formats: Stability and preservative efficacy study.
Anan Bzami, Changcheng Zhu, Marcus Estrada, Jessica A White, Manjari Lal

Vaccine X· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of MPBT Assay for Multiplex Determination of Infectious Titers and for Selection of the Optimal Formulation for the Trivalent Novel Oral Poliovirus Vaccine.
Hasmik Manukyan, Manjari Lal, Changcheng Zhu, Olga Singh, Tsai-Lien Lin

Viruses· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Anh Duc Dang, Thiem Dinh Vu, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Manjari Lal

Vaccine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation.
Changcheng Zhu, Manjari Lal

Pharmaceutics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial.
Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Manjari Lal

EClinicalMedicine· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial.
Punnee Pitisuttithum, Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Manjari Lal

medRxiv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Freeze-dried tablets for oral vaccine delivery: Ease of administration and potential for production in existing facilities.
Manjari Lal

Vaccine· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility Study for the Rectal Route of Administration for Gentamicin Evaluated in the Neonatal Minipig Model.
David H McAdams, Manjari Lal, Manshun Lai, Manjari Quintanar-Solares

J Pharm Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical product attributes in development of an oral enteric vaccine for infants.
Jessica A White, Manjari Lal

Vaccine· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.
Manjari Lal, Manshun Lai, Shweta Ugaonkar, Asa Wesenberg, Larisa Kizima

J Pharm Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.
Nina Derby, Manjari Lal, Meropi Aravantinou, Larisa Kizima, Patrick Barnable

Nat Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heat-stable sublingual oxytocin tablets as a potential needle-free approach for preventing postpartum hemorrhage in low-resource settings.
Changcheng Zhu, Marcus Estrada, Jessica White, Manjari Lal

Drug Deliv Transl Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparing an Adjuvanted Thermoresponsive Gel Formulation for Sublingual Vaccination.
Manjari Lal, Jessica White, Changcheng Zhu

Methods Mol Biol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation.
David W Pittman, Alexandra M Brantly, Alexandra L Drobonick, Hannah T King, Daniel C Mesta, Manjari Lal

AIDS Res Treat· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine.
Jessica A White, Candace Haghighi, Johanna Brunner, Marcus Estrada, Manjari Lal

J Immunol Methods· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a Flexible Pediatric Dosage Form for Antiretroviral Therapy: A Fast-Dissolving Tablet.
Manjari Lal, Manshun Lai, Marcus Estrada, Changcheng Zhu

J Pharm Sci· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presentation matters: Buffers, packaging, and delivery devices for new, oral enteric vaccines for infants.
Manjari Lal, Courtney Jarrahian

Hum Vaccin Immunother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers.
Manjari Lal, Courtney Jarrahian, Changcheng Zhu, Nancy A Hosken, Chris L McClurkan

Vaccine· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of different buffers to maximize viability of an oral Shigella vaccine.
Lakshmi Chandrasekaran, Manjari Lal, Lillian L Van De Verg, Malabi M Venkatesan

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.
Jessica A White, Jeremy S Blum, Nancy A Hosken, Joshua O Marshak, Lauren Duncan, Manjari Lal

Hum Vaccin Immunother· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up.
Changcheng Zhu, Yoko Shoji, Scott McCray, Michael Burke, Caitlin E Hartman, Manjari Lal

Pharm Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
Manjari Lal, Scott Priddy, Lou Bourgeois, Richard Walker, Walt Pebley

Vaccine· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a thermostable hepatitis B vaccine formulation.
LaToya Jones Braun, Jan Jezek, Sabrina Peterson, Anil Tyagi, Shalimar Perkins, Manjari Lal

Vaccine· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis